BE764216A - Compositions therapeutiques a injecter - Google Patents

Compositions therapeutiques a injecter

Info

Publication number
BE764216A
BE764216A BE764216A BE764216A BE764216A BE 764216 A BE764216 A BE 764216A BE 764216 A BE764216 A BE 764216A BE 764216 A BE764216 A BE 764216A BE 764216 A BE764216 A BE 764216A
Authority
BE
Belgium
Prior art keywords
injected
therapeutic compositions
therapeutic
compositions
Prior art date
Application number
BE764216A
Other languages
English (en)
French (fr)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10002863&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE764216(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of BE764216A publication Critical patent/BE764216A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
BE764216A 1970-03-13 1971-03-12 Compositions therapeutiques a injecter BE764216A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1234870 1970-03-13

Publications (1)

Publication Number Publication Date
BE764216A true BE764216A (fr) 1971-09-13

Family

ID=10002863

Family Applications (1)

Application Number Title Priority Date Filing Date
BE764216A BE764216A (fr) 1970-03-13 1971-03-12 Compositions therapeutiques a injecter

Country Status (19)

Country Link
US (1) US4031214A (xx)
JP (1) JPS5317647B1 (xx)
AT (1) AT304147B (xx)
BE (1) BE764216A (xx)
CA (1) CA940450A (xx)
DK (1) DK128229B (xx)
ES (1) ES389164A1 (xx)
FI (1) FI50766C (xx)
FR (1) FR2085703B1 (xx)
GB (1) GB1347472A (xx)
IE (1) IE35013B1 (xx)
IL (1) IL36409A (xx)
IT (1) IT1011004B (xx)
KE (1) KE2738A (xx)
NL (1) NL168704C (xx)
NO (1) NO133649C (xx)
SE (1) SE386823B (xx)
ZA (1) ZA711632B (xx)
ZM (1) ZM3271A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK136934B (da) * 1976-02-06 1977-12-19 Rosco As Fremgangsmåde til fremstilling af en klar, stabil, injicerbar opløsning indeholdende et sulfonamid og en potentiator.
EP0007591B1 (de) * 1978-08-01 1982-07-28 Ciba-Geigy Ag Stabile flüssige Arzneimittelformulierung auf Basis von 2,6-Diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidin(Trimethoprim) und einem Sulfonamid, Verfahren zu ihrer Herstellung und ihre Verwendung
AR220263A1 (es) * 1980-02-19 1980-10-15 Bago Lab Sa Procedimiento para obtener una preparacion inyectable de sulfonamida potenciada de baja irritabilidad
DE3278126D1 (en) * 1981-09-30 1988-03-31 Nat Res Dev Sustained release compositions
US5335675A (en) * 1988-11-15 1994-08-09 Family Health International Stress-softened elastomeric films, articles, and method and apparatus for making such films and articles
US5135924A (en) * 1989-01-03 1992-08-04 Hoffmann-La Roche Inc. Therapeutic treatment of animals with oral administration of ormetoprim-potentiated sulfonamides
US6211185B1 (en) 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent
CA2598668A1 (en) * 2005-02-25 2006-09-08 Mutual Pharmaceutical Company, Inc. Dosage forms of antibiotics and combinations of antibiotics and symptomatic relief agents
CN113712914A (zh) * 2021-10-18 2021-11-30 杭州艾贝德生命科技研究院有限公司 一种复方磺胺嘧啶混悬液的制备方法
CN113952296B (zh) * 2021-11-15 2023-10-13 山东新华制药股份有限公司 一种复方磺胺甲噁唑注射液的制备方法
CN118304259A (zh) * 2024-04-10 2024-07-09 南京康川济医药科技有限公司 一种复方磺胺甲噁唑注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
US3728452A (en) * 1971-01-20 1973-04-17 Abic Ltd Water-soluble composition comprising sulfadimidine and pyrimethamine

Also Published As

Publication number Publication date
IT1011004B (it) 1977-01-20
FR2085703A1 (xx) 1971-12-31
SE386823B (sv) 1976-08-23
NL168704B (nl) 1981-12-16
FR2085703B1 (xx) 1974-05-31
IL36409A0 (en) 1971-05-26
IE35013B1 (en) 1975-10-15
ZA711632B (en) 1972-10-25
ZM3271A1 (en) 1972-10-23
FI50766B (xx) 1976-03-31
US4031214A (en) 1977-06-21
CA940450A (en) 1974-01-22
KE2738A (en) 1977-06-10
GB1347472A (en) 1974-02-27
NL168704C (nl) 1982-05-17
ES389164A1 (es) 1974-09-01
DE2112049A1 (de) 1971-09-23
JPS5317647B1 (xx) 1978-06-09
NO133649B (xx) 1976-03-01
AT304147B (de) 1972-12-27
IL36409A (en) 1974-01-14
NO133649C (xx) 1976-06-09
DK128229B (da) 1974-03-25
NL7103335A (xx) 1971-09-15
IE35013L (en) 1971-09-13
FI50766C (fi) 1976-07-12

Similar Documents

Publication Publication Date Title
BE756238A (fr) Compositions a expanser
FI56018B (fi) Foerfarande foer framstaellning av 5-azapyrimidinnukleosider
BE761599A (fr) Compositions a polir
SE412586B (sv) Sett att framstella isoflavonderivat
AT297282B (de) Vorzufertigendes Bauelement
IT968027B (it) Perfezionamenti relativi a dentiere
BE764216A (fr) Compositions therapeutiques a injecter
ZA712087B (en) Improvements relating to knitting
CH540698A (de) Injektionsspritze
AR193612A1 (es) Conjunto de elementos para ser utilizado como juguete
FR2002454A1 (fr) Composition medicinale injectable
ZA715393B (en) Improvements relating to azepine-derivatives
BE774701A (fr) Memoires a transistors
AT306999B (de) Injektionsanker
BE765058A (fr) Compositions pour detruire les acariens
IT1043837B (it) Procedimento per preparare cicloal can 1 3 oioni bisostituiti in posizione 2 2
ZA712788B (en) Improvements relating to phenylaminoalkanes
ZA716643B (en) Improvements relating to 1-phenoxy-2-hydroxy-3-hydroxyalkylaminopropanes
IT944113B (it) Omerello a perdere
BR7107958D0 (pt) Aperfeicoamentos relativos a dispositivos anticoncepcionais
BE773133A (fr) Melange synergique
IT944270B (it) Procedimento per ottenere idroge noclorosilani
IT972978B (it) Composizioni destinate a essere impiegate come base per shampi
BE820235A (fr) Composition therapeutique a injecter
FI53451C (fi) Foerfarande foer framstaellning av (+-)-4-hydroxifenylglycin

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: THE WELLCOME FOUNDATION LTD

Effective date: 19910312